Cargando…

Inflammatory breast cancer (IBC): clues for targeted therapies

Inflammatory breast cancer (IBC) is the most aggressive type of advanced breast cancer characterized by rapid proliferation, early metastatic development and poor prognosis. Since there are few preclinical models of IBC, there is a general lack of understanding of the complexity of the disease. Rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez, Sandra V., Robertson, Fredika M., Pei, Jianming, Aburto-Chumpitaz, Lucy, Mu, Zhaomei, Chu, Khoi, Alpaugh, R. K., Huang, Yong, Cao, Yu, Ye, Zaiming, Cai, Kathy Q., Boley, Kimberly M., Klein-Szanto, Andres J., Devarajan, Karthik, Addya, Sankar, Cristofanilli, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2013
Materias:	Preclinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273486/ https://www.ncbi.nlm.nih.gov/pubmed/23784380 http://dx.doi.org/10.1007/s10549-013-2600-4

Ejemplares similares

Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC)
por: Gong, Yulan, et al.
Publicado: (2021)

Presence of anaplastic lymphoma kinase in inflammatory breast cancer
por: Robertson, Fredika M, et al.
Publicado: (2013)

Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients
por: Bingham, Catherine, et al.
Publicado: (2017)

Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC
por: Rypens, Charlotte, et al.
Publicado: (2022)

The Paradox of E-Cadherin: Role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism
por: Chu, Khoi, et al.
Publicado: (2013)

Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium
por: Devi, Gayathri R., et al.
Publicado: (2019)

EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells
por: Mu, Zhaomei, et al.
Publicado: (2013)

Select agent program impact on the IBC
por: Adamovicz, Jeffery
Publicado: (2016)

The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells
por: Salem, Israa, et al.
Publicado: (2016)

US federal oversight of biological materials and the IBC
por: Howard, Deborah
Publicado: (2016)

Strengthening the role of the IBC in the 21st century
por: Buller, R. Mark, et al.
Publicado: (2016)

IBCs – A cornerstone of public trust in research
por: Harris, Kathryn L., et al.
Publicado: (2016)

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
por: Iwase, Toshiaki, et al.
Publicado: (2020)

Antibacterial Activity of Isobavachalcone (IBC) Is Associated with Membrane Disruption
por: de Assis, Leticia Ribeiro, et al.
Publicado: (2022)

Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center
por: Fouad, Tamer M., et al.
Publicado: (2018)

Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China
por: Liu, Xiaoran, et al.
Publicado: (2021)

IBC – Proteomics, 1–2 March 2000, Basel Hilton, Switzerland
por: Masterson, Philip John
Publicado: (2001)

Intelligent Bayes Classifier (IBC) for ENT infection classification in hospital environment
por: Dutta, Ritaban, et al.
Publicado: (2006)

IBC CARe Microarray Allelic Population Prevalences in an American Indian Population
por: Best, Lyle G., et al.
Publicado: (2013)

Identification of protein antigens of group B streptococci, with special reference to the Ibc antigens
Publicado: (1984)

Overcoming regulatory gaps in biological materials oversight by enhancing IBC protocol review
por: Rainer, David, et al.
Publicado: (2016)

iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System
por: Hastedt, Jayne E., et al.
Publicado: (2022)

MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis
por: Dutta, Pranabananda, et al.
Publicado: (2018)

Hydrogen Sulfide Attenuates Renin Angiotensin and Aldosterone Pathological Signaling to Preserve Kidney Function and Improve Exercise Tolerance in Heart Failure
por: Li, Zhen, et al.
Publicado: (2018)

Increased Afterload Augments Sunitinib-Induced Cardiotoxicity in an Engineered Cardiac Microtissue Model
por: Truitt, Rachel, et al.
Publicado: (2018)

Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants
por: Al Amri, Waleed S., et al.
Publicado: (2020)

Innovation in biosafety oversight: The Harvard Catalyst Common Reciprocal IBC Reliance Authorization Agreement
por: Caruso, Rebecca, et al.
Publicado: (2020)

Separating the two polarities of the POLO contacts of an 26.1%-efficient IBC solar cell
por: Hollemann, C., et al.
Publicado: (2020)

ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer
por: Ku, Bo Mi, et al.
Publicado: (2022)

Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry
por: Zell, Jason A, et al.
Publicado: (2009)

Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer
por: Ku, Bo Mi, et al.
Publicado: (2019)

Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis
por: Lewis Phillips, Gail D., et al.
Publicado: (2017)

Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10(th) Anniversary Conference
por: Woodward, Wendy A., et al.
Publicado: (2017)

Acute Kidney Injury Results in Long-Term Diastolic Dysfunction That Is Prevented by Histone Deacetylase Inhibition
por: Soranno, Danielle E., et al.
Publicado: (2021)

The therapeutic potential of RNA Polymerase I transcription inhibitor, CX-5461, in uterine leiomyosarcoma
por: Kang, Chang-Won, et al.
Publicado: (2022)

Macrophage-Derived Exosomal Mir-155 Regulating Cardiomyocyte Pyroptosis and Hypertrophy in Uremic Cardiomyopathy
por: Wang, Bin, et al.
Publicado: (2020)

Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors
por: Grenader, Tal, et al.
Publicado: (2020)

AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models
por: Mu, Zhaomei, et al.
Publicado: (2014)

Therapeutic Antibody Against Phosphorylcholine Preserves Coronary Function and Attenuates Vascular (18)F-FDG Uptake in Atherosclerotic Mice
por: Ståhle, Mia, et al.
Publicado: (2020)

Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)()
por: Joglekar-Javadekar, Madhura, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p3l3nq2l8o583hr8gsb153oulj